Indigo Diabetes nets Series B

Indigo Diabetes, a developer of a glucose monitoring device for diabetics, has secured 38 million euros in Series B funding.

27 July 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles